Global Pet Diabetes Care Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Device;

Insulin Delivery Devices, Insulin Delivery Pen, Insulin Syringes, and Glucose Monitoring Devices.

By Animal Type;

Cats, Dogs, and Horses.

By End-Use;

Veterinary Clinics, Home Care Settings, and Veterinary Hospitals.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn114468384 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Pet Diabetes Care Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Pet Diabetes Care Devices Market was valued at USD 2,386.27 million. The size of this market is expected to increase to USD 4,224.03 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.5%.

The Global Pet Diabetes Care Devices Market is a rapidly growing segment within the broader pet care industry, driven by the increasing prevalence of diabetes among pets, particularly dogs and cats. As pets live longer and their health concerns become more complex, conditions such as diabetes are becoming more common, particularly in aging pets or those with underlying health issues such as obesity. Pet diabetes, especially insulin-dependent diabetes, requires ongoing management to ensure pets lead healthy, active lives. The market for diabetes care devices is thus expanding as more pet owners seek effective, reliable, and user-friendly solutions to monitor and manage their pets' blood glucose levels. These devices, which include blood glucose meters, insulin pumps, continuous glucose monitors (CGMs), and other related technologies, offer pet owners the tools they need to maintain their pets' health and avoid serious complications related to diabetes.

Advancements in diabetes care technology are contributing to the growth of the market, with innovations that provide greater accuracy, ease of use, and convenience for pet owners. Devices like glucose monitoring systems and insulin pumps are becoming increasingly sophisticated, enabling more precise treatment and reducing the risk of diabetes-related complications in pets. For instance, pet owners can now use advanced blood glucose monitors designed specifically for pets, which feature pet-friendly features like smaller blood sample sizes and pet-specific readings. Additionally, the growing awareness of the importance of early detection and monitoring is prompting more pet owners to seek out regular testing and better management solutions. This growing focus on preventive care is helping to normalize the use of medical devices in managing chronic conditions like diabetes, increasing their acceptance and adoption among pet owners.

As the global pet care market continues to evolve, the increasing emphasis on pet health and wellness is providing a significant push for the diabetes care devices market. Rising pet ownership, particularly among millennial and Gen Z pet parents, who view their pets as family members, is driving demand for high-quality, personalized, and comprehensive care solutions. These pet owners are more likely to invest in products that ensure their pets' long-term health, including devices for chronic conditions like diabetes. Additionally, the increasing availability of veterinary services, the rising trend of pet insurance, and improved access to specialized medical care for pets further fuel the adoption of diabetes management devices. The market is expected to continue growing as both pet owners and veterinarians increasingly prioritize the long-term well-being of diabetic pets, contributing to the overall expansion of the Global Pet Diabetes Care Devices Market.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Device
    2. Market Snapshot, By Animal Type
    3. Market Snapshot, By End-Use
    4. Market Snapshot, By Region
  4. Global Pet Diabetes Care Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Diabetes in Pets
        2. Advancements in Pet Diabetes Care Technology
        3. Growing Awareness of Pet Health and Wellness
      2. Restraints
        1. High Cost of Diabetes Care Devices
        2. Lack of Awareness in Developing Regions
        3. Complexity of Usage
      3. Opportunities
        1. Innovation in User-Friendly Devices
        2. Growth of Pet Insurance
        3. Expansion into Emerging Markets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Pet Diabetes Care Devices Market, By Device, 2021 - 2031 (USD Million)
      1. Insulin Delivery Devices
      2. Insulin Delivery Pen
      3. Insulin Syringes
      4. Glucose Monitoring Devices
    2. Global Pet Diabetes Care Devices Market, By Animal Type, 2021 - 2031 (USD Million)
      1. Cats
      2. Dogs
      3. Horses
    3. Global Pet Diabetes Care Devices Market, By End-Use, 2021 - 2031 (USD Million)
      1. Veterinary clinics
      2. Home care settings
      3. Veterinary hospitals
    4. Global Pet Diabetes Care Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbot Laboratories, Inc
      2. Virbac
      3. Medtronic plc
      4. Johnson & Johnson Services, Inc
      5. Roche Diagnostics
      6. Bio-Rad Laboratories, Inc
      7. Novo Nordisk A/S
      8. Zoetis Inc
      9. Terumo Corporation
      10. Boehringer Ingelheim International GmbH
      11. IDEXX Laboratories
      12. Johnson & Johnson Services, Inc
      13. Terumo Corporation
      14. Eli Lilly and Company
      15. Vetoquinol S.A.
  7. Analyst Views
  8. Future Outlook of the Market